Non-clear cell renal cell carcinoma: does the mammalian target of rapamycin represent a rational therapeutic target?
Albiges, Laurence; Molinie, Vincent; Escudier, Bernard.
; 17(8): 1051-62, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22807514
Heavy Metal Enlightens Tumor Immunity.
SnapShot: Renal Cell Carcinoma.
Partial nephrectomy versus radical nephrectomy for clinical localised renal masses.
Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor.
An Immune Atlas of Clear Cell Renal Cell Carcinoma.
High grade infiltrative adenocarcinomas of renal cell origin: New insights into classification, morphology, and molecular pathogenesis.
The G-protein-coupled receptor CLR is upregulated in an autocrine loop with adrenomedullin in clear cell renal cell carcinoma and associated with poor prognosis.
[Intravoxel incoherent motion dwi in renal tumors: differentiation between benign and malignant masses].
[Clinical and pathological analysis of small renal cell carcinoma].
Molecular profiling of renal cell carcinoma: building a bridge toward clinical impact.